Stryker recalls UHMWPE orthopaedic implant components over material aging
The affected products are implanted orthopaedic components, and the FDA record links increased material oxidation to wear-related outcomes that may include pain, inflammation, and revision surgery. For manufacturers, the event also illustrates how raw-material aging controls and process-change governance can propagate across numerous implant configurations and product families.